Back to DODGE & COX DODGE & COX

GSKGSK
16 quarters

Position history for DODGE & COXDODGE & COX's holdings in GLAXOSMITHKLINE PLC-SPON ADR

DODGE & COX holds 48.2M shares of GSK (GLAXOSMITHKLINE PLC-SPON ADR), worth $2.5B as of 2026-Q2. The position was decreased (-17.8% shares). GSK represents 1.3% of DODGE & COX's portfolio.

Current Value

$2.5B

Current Shares

48.2M

Total Value Change

+$802.4M

Total Shares Change

-10.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
48.2M
-17.8%
$2.5B1.3%$51.95
0
2026-Q1
Decreased
58.7M
-14.4%
$3.2B1.8%$54.20
0
2025-Q4
Decreased
68.5M
-12.6%
$3.4B1.8%$47.78
0
2025-Q3
Decreased
78.4M
-0.5%
$3.4B1.8%$41.68
0
2025-Q2
Increased
78.8M
+0.1%
$3B1.7%$36.68
50
2025-Q1
Increased
78.7M
+14.9%
$3B1.7%$36.58
58
2024-Q4
Increased
68.4M
+0.5%
$2.3B1.3%$31.59
50
2024-Q3
Decreased
68.1M
-0.4%
$2.8B1.6%$37.75
0
2024-Q2
Decreased
68.3M
-0.8%
$2.6B1.6%$35.22
0
2024-Q1
Decreased
68.9M
-0.2%
$3B1.7%$38.90
0
2023-Q4
Decreased
69M
-0.4%
$2.6B1.6%$33.30
0
2023-Q3
Decreased
69.3M
-0.5%
$2.5B1.7%$32.25
0
2023-Q2
Decreased
69.6M
-0.1%
$2.5B1.7%$31.38
0
2023-Q1
Increased
69.7M
+7.3%
$2.5B1.7%$31.03
54
2022-Q4
Increased
64.9M
+10.8%
$2.3B1.6%$30.35
56
2022-Q3
New
58.6M
-
$1.7B1.3%$25.18
73

Other major holders of GSK: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used